pehub.com -- ReVance Therapeutics Inc., a Mountain View, Calif.-based drug developer focused on dermatology and aesthetic medicine, has raised $25.62 million in Series D funding, according to a regulatory filing.
pehub.com -- ReVance Therapeutics Inc., a Mountain View, Calif.-based drug developer focused on dermatology and aesthetic medicine, has raised $25.62 million in Series D funding, according to a regulatory filing.
